Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt No Debt
MBLX's Cash to Debt is ranked higher than
99% of the 1110 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.38 vs. MBLX: No Debt )
MBLX' s 10-Year Cash to Debt Range
Min: 9.28   Max: No Debt
Current: No Debt

Equity to Asset 0.85
MBLX's Equity to Asset is ranked higher than
95% of the 1102 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.51 vs. MBLX: 0.85 )
MBLX' s 10-Year Equity to Asset Range
Min: -6.36   Max: 0.95
Current: 0.85

-6.36
0.95
Interest Coverage No Debt
MBLX's Interest Coverage is ranked higher than
93% of the 738 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 21.02 vs. MBLX: No Debt )
MBLX' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 3
Z-Score: -11.23
M-Score: -2.97
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -714.17
MBLX's Operating margin (%) is ranked lower than
64% of the 1122 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.85 vs. MBLX: -714.17 )
MBLX' s 10-Year Operating margin (%) Range
Min: -8691.74   Max: 8.51
Current: -714.17

-8691.74
8.51
Net-margin (%) -706.46
MBLX's Net-margin (%) is ranked lower than
64% of the 1122 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.99 vs. MBLX: -706.46 )
MBLX' s 10-Year Net-margin (%) Range
Min: -8661.38   Max: 8.58
Current: -706.46

-8661.38
8.58
ROE (%) -171.13
MBLX's ROE (%) is ranked lower than
64% of the 1102 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.11 vs. MBLX: -171.13 )
MBLX' s 10-Year ROE (%) Range
Min: -122.86   Max: 8.36
Current: -171.13

-122.86
8.36
ROA (%) -136.56
MBLX's ROA (%) is ranked lower than
64% of the 1123 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.75 vs. MBLX: -136.56 )
MBLX' s 10-Year ROA (%) Range
Min: -518.55   Max: 5.32
Current: -136.56

-518.55
5.32
ROC (Joel Greenblatt) (%) -2578.66
MBLX's ROC (Joel Greenblatt) (%) is ranked lower than
65% of the 1121 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 10.06 vs. MBLX: -2578.66 )
MBLX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -2836.08   Max: 198.29
Current: -2578.66

-2836.08
198.29
Revenue Growth (3Y)(%) 100.00
MBLX's Revenue Growth (3Y)(%) is ranked higher than
99% of the 954 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.40 vs. MBLX: 100.00 )
MBLX' s 10-Year Revenue Growth (3Y)(%) Range
Min: -58.5   Max: 173.7
Current: 100

-58.5
173.7
EBITDA Growth (3Y)(%) -14.80
MBLX's EBITDA Growth (3Y)(%) is ranked higher than
52% of the 883 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.90 vs. MBLX: -14.80 )
MBLX' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 4.5
Current: -14.8

0
4.5
EPS Growth (3Y)(%) -15.30
MBLX's EPS Growth (3Y)(%) is ranked higher than
57% of the 798 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.00 vs. MBLX: -15.30 )
MBLX' s 10-Year EPS Growth (3Y)(%) Range
Min: -18.2   Max: 4.5
Current: -15.3

-18.2
4.5
» MBLX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

MBLX Guru Trades in Q4 2013

Jim Simons 67,500 sh (+34.69%)
» More
Q1 2014

MBLX Guru Trades in Q1 2014

Jim Simons 51,900 sh (-23.11%)
» More
Q2 2014

MBLX Guru Trades in Q2 2014

Jim Simons 56,507 sh (+8.88%)
» More
Q3 2014

MBLX Guru Trades in Q3 2014

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MBLX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.44
MBLX's P/B is ranked higher than
95% of the 1169 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.83 vs. MBLX: 0.44 )
MBLX' s 10-Year P/B Range
Min: 0.44   Max: 18.75
Current: 0.44

0.44
18.75
P/S 2.58
MBLX's P/S is ranked higher than
50% of the 1169 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.01 vs. MBLX: 2.58 )
MBLX' s 10-Year P/S Range
Min: 0.93   Max: 1217
Current: 2.58

0.93
1217
EV-to-EBIT -0.64
MBLX's EV-to-EBIT is ranked lower than
54% of the 1169 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 19.49 vs. MBLX: -0.64 )
MBLX' s 10-Year EV-to-EBIT Range
Min: -114.7   Max: 18.4
Current: -0.64

-114.7
18.4
Current Ratio 6.49
MBLX's Current Ratio is ranked higher than
96% of the 1116 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.75 vs. MBLX: 6.49 )
MBLX' s 10-Year Current Ratio Range
Min: 1.43   Max: 38.31
Current: 6.49

1.43
38.31
Quick Ratio 6.29
MBLX's Quick Ratio is ranked higher than
97% of the 1116 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.20 vs. MBLX: 6.29 )
MBLX' s 10-Year Quick Ratio Range
Min: 1.43   Max: 38.31
Current: 6.29

1.43
38.31

Valuation & Return

vs
industry
vs
history
Price/Net Cash 0.52
MBLX's Price/Net Cash is ranked higher than
100% of the 1169 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9999.00 vs. MBLX: 0.52 )
MBLX' s 10-Year Price/Net Cash Range
Min: 1.34   Max: 27.66
Current: 0.52

1.34
27.66
Price/Net Current Asset Value 0.50
MBLX's Price/Net Current Asset Value is ranked higher than
100% of the 1166 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9999.00 vs. MBLX: 0.50 )
MBLX' s 10-Year Price/Net Current Asset Value Range
Min: 1.28   Max: 27.66
Current: 0.5

1.28
27.66
Price/Tangible Book 0.44
MBLX's Price/Tangible Book is ranked higher than
96% of the 1169 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.41 vs. MBLX: 0.44 )
MBLX' s 10-Year Price/Tangible Book Range
Min: 1.01   Max: 18.44
Current: 0.44

1.01
18.44
Price/Median PS Value 0.02
MBLX's Price/Median PS Value is ranked higher than
100% of the 1169 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.14 vs. MBLX: 0.02 )
MBLX' s 10-Year Price/Median PS Value Range
Min: 0.01   Max: 11.27
Current: 0.02

0.01
11.27
Earnings Yield (Greenblatt) -156.30
MBLX's Earnings Yield (Greenblatt) is ranked lower than
65% of the 1108 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.60 vs. MBLX: -156.30 )
MBLX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.4   Max: 760.5
Current: -156.3

5.4
760.5

Business Description

Industry: Chemicals » Specialty Chemicals
Compare:NEU, SCL, VAL, POL, CYT » details
Traded in other countries:M6X.Germany,
Metabolix Inc was incorporated in Massachusetts in June 1992 under the name Metabolix, Inc. In September 1998, it reincorporated in Delaware. The Company is an innovation-driven bioscience company focused on delivering sustainable solutions to the plastics and chemicals industries. It is engaged in products and markets development of a biopolymer platform, based on technology developed by the Company and early commercialization efforts conducted through the Telles joint venture with ADM. It has core capabilities in microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science, and has assembled these capabilities in a way that has allowed the Company to integrate its biotechnology research with real world chemical engineering and industrial practice. It has created an intellectual property portfolio to protect its innovations and, together with its technology, to serve as a valuable foundation for future industry collaborations. It has focused on a family of biopolymers found in nature called polyhydroxyalkanoates "PHA", which occur naturally in living organisms and are chemically similar to polyesters. It has demonstrated the production of PHAs at industrial scale to produce PHA biopolymers and PHA precursors to biobased industrial chemicals. It has also demonstrated the production of polyhydroxybutyrate, a subclass of PHAs, in agriculturally significant non-food crops. Polymers are found in nature in a range of organisms including microbes, plants and animals. The Company competes with Dow Chemical, DuPont, BASF, Ineos, LyondellBasell, SABIC, Mitsubishi Chemical, DuPont, DSM, Arkema and Braskem. The Company is subject to significant foreign and domestic government regulations, and compliance or failure to comply with these regulations could harm its business.
» More Articles for MBLX

Headlines

Articles On GuruFocus.com
5 Biggest Losers of Magic Formula Investing in 2013 Dec 18 2013 
comment on MBLX Sep 25 2012 
comment on MBLX Aug 07 2012 
METABOLIX, INC. Reports Operating Results (10-K) Mar 10 2011 
Market Neutral Trade for 2.10.2011: Long EMN, Short MBLX Feb 10 2011 
METABOLIX, INC. Reports Operating Results (10-Q) Nov 09 2010 
METABOLIX, INC. Reports Operating Results (10-Q) Jul 29 2010 
METABOLIX, INC. Reports Operating Results (10-Q) May 03 2010 
METABOLIX, INC. Reports Operating Results (10-Q) Nov 03 2009 
METABOLIX, INC. Reports Operating Results (10-Q) Aug 06 2009 

More From Other Websites
Nasdaq stocks posting largest volume increases Dec 18 2014
METABOLIX, INC. Financials Nov 21 2014
10-Q for Metabolix, Inc. Nov 16 2014
METABOLIX, INC. Files SEC form 10-Q, Quarterly Report Nov 14 2014
Metabolix Announces Third Quarter 2014 Financial Results Nov 05 2014
Metabolix Inc Earnings Call scheduled for 4:30 pm ET today Nov 05 2014
METABOLIX, INC. Files SEC form 8-K, Change in Directors or Principal Officers Nov 05 2014
Metabolix Announces Third Quarter 2014 Financial Results Nov 05 2014
METABOLIX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other... Nov 03 2014
METABOLIX, INC. Files SEC form 8-K, Other Events Oct 21 2014
Metabolix to Conduct Webcast of Its Third Quarter Fiscal Year 2014 Earnings Call Oct 21 2014
Metabolix to Conduct Webcast of Its Third Quarter Fiscal Year 2014 Earnings Call Oct 21 2014
Metabolix to Present Data Showing That Biobased PHA Copolymers Deliver Key Performance Improvements... Oct 20 2014
Metabolix to Present Data Showing That Biobased PHA Copolymers Deliver Key Performance Improvements... Oct 20 2014
METABOLIX, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Material... Oct 06 2014
METABOLIX, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and... Aug 25 2014
Metabolix, Inc. Closes $25 Million Private Placement Aug 25 2014
METABOLIX, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and... Aug 11 2014
Metabolix Granted Financial Viability Exception By NASDAQ Aug 11 2014
METABOLIX, INC. Files SEC form 10-Q, Quarterly Report Aug 08 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK